IL100646A - History of N-imidazolyl of tetrahydrocarbazoles and cycloheft [B] - Transformed indoles, their preparation and their pharmaceutical preparations - Google Patents

History of N-imidazolyl of tetrahydrocarbazoles and cycloheft [B] - Transformed indoles, their preparation and their pharmaceutical preparations

Info

Publication number
IL100646A
IL100646A IL10064692A IL10064692A IL100646A IL 100646 A IL100646 A IL 100646A IL 10064692 A IL10064692 A IL 10064692A IL 10064692 A IL10064692 A IL 10064692A IL 100646 A IL100646 A IL 100646A
Authority
IL
Israel
Prior art keywords
imidazol
compound
phenyl
formula
methyl
Prior art date
Application number
IL10064692A
Other languages
English (en)
Hebrew (he)
Other versions
IL100646A0 (en
Inventor
Paolo Cozzi
Antonio Pillan
Maurizio Pulici
Patricia Salvati
Angelo Daniele Volpi
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL100646A0 publication Critical patent/IL100646A0/xx
Publication of IL100646A publication Critical patent/IL100646A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
IL10064692A 1991-01-22 1992-01-14 History of N-imidazolyl of tetrahydrocarbazoles and cycloheft [B] - Transformed indoles, their preparation and their pharmaceutical preparations IL100646A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919101375A GB9101375D0 (en) 1991-01-22 1991-01-22 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole

Publications (2)

Publication Number Publication Date
IL100646A0 IL100646A0 (en) 1992-09-06
IL100646A true IL100646A (en) 1995-11-27

Family

ID=10688812

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10064692A IL100646A (en) 1991-01-22 1992-01-14 History of N-imidazolyl of tetrahydrocarbazoles and cycloheft [B] - Transformed indoles, their preparation and their pharmaceutical preparations

Country Status (18)

Country Link
US (1) US5238953A (es)
EP (1) EP0496237B1 (es)
JP (1) JPH04321683A (es)
KR (1) KR920014806A (es)
AT (1) ATE134191T1 (es)
AU (1) AU641837B2 (es)
CA (1) CA2059741A1 (es)
DE (1) DE69208271D1 (es)
FI (1) FI920247A (es)
GB (1) GB9101375D0 (es)
HU (1) HUT60492A (es)
IE (1) IE920173A1 (es)
IL (1) IL100646A (es)
MX (1) MX9200178A (es)
MY (1) MY106807A (es)
NZ (1) NZ241317A (es)
TW (1) TW203610B (es)
ZA (1) ZA92428B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685122B2 (en) * 1993-06-14 1998-01-15 Pfizer Inc. Imidazole lipoxygenase inhibitors
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US6713645B1 (en) * 1996-10-30 2004-03-30 Eli Lilly And Company Substituted tricyclics
US6177440B1 (en) 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
US6410583B1 (en) 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE486478A (es) * 1947-12-24
GB1418703A (en) * 1973-06-02 1975-12-24 Pfizer Ltd 3-alkyl-9-substituted-1,2,3,4-tetrahydrocarbazoles
CA1046519A (en) * 1975-08-28 1979-01-16 American Home Products Corporation Trycyclic acetic acid derivatives
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4436746A (en) * 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
ES2038653T3 (es) * 1986-01-23 1993-08-01 Merck Frosst Canada Inc. Acidos 1-alcanoicos tetrahidrocarbazol.
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
CA1326030C (en) * 1987-07-21 1994-01-11 John W. Gillard Cyclohept[b]indolealkanoic acids
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5187180A (en) * 1990-07-26 1993-02-16 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes

Also Published As

Publication number Publication date
ATE134191T1 (de) 1996-02-15
CA2059741A1 (en) 1992-07-23
US5238953A (en) 1993-08-24
HU9200190D0 (en) 1992-04-28
IL100646A0 (en) 1992-09-06
ZA92428B (en) 1992-10-28
AU1020792A (en) 1992-07-30
DE69208271D1 (de) 1996-03-28
EP0496237B1 (en) 1996-02-14
NZ241317A (en) 1993-08-26
EP0496237A2 (en) 1992-07-29
TW203610B (es) 1993-04-11
GB9101375D0 (en) 1991-03-06
FI920247A (fi) 1992-07-23
IE920173A1 (en) 1992-07-29
HUT60492A (en) 1992-09-28
EP0496237A3 (en) 1992-12-09
FI920247A0 (fi) 1992-01-20
JPH04321683A (ja) 1992-11-11
AU641837B2 (en) 1993-09-30
MY106807A (en) 1995-07-31
MX9200178A (es) 1992-07-01
KR920014806A (ko) 1992-08-25

Similar Documents

Publication Publication Date Title
US4643998A (en) Imidazolylalkylthienyl tetrahydropyridazines and processes for their use
US4510149A (en) N-Imidazolyl derivatives containing naphthalene or indene nucleus
US5246957A (en) N-imidazolyl derivatives of substituted indole
EP0630374A1 (en) Imidazole, triazole and tetrazole derivatives
US5554629A (en) 4-substituted 1,2,4-triazole derivatives
EP0117462A2 (en) N-(2-4-(1H-imidazol-1-yl)alkyl)arylamides
US5204364A (en) N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds
IE54473B1 (en) Imidazolylphenyl-tetrahydropyridazines, processes for their preparation and pharmaceutical preparations containing them
EP0496237B1 (en) N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b]indole
AU644632B2 (en) Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
EP0293500A1 (en) 3-heteroalkyl-2,4.quinzaoline-diones
RU2083566C1 (ru) N-имидазолильные производные замещенных алкоксииминотетрагидронафталинов или хроманов или их фармацевтически приемлемые соли и фармацевтическая композиция, проявляющая активность антагониста тромбоксана и ингибитора тромбоксансинтазы
US5283254A (en) 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid derivatives
JPH11510177A (ja) 置換1−インドリルプロピル−4−フェネチルピペラジン誘導体
JPS6016975A (ja) 双環性化合物のn−イミダゾリル誘導体およびそれらの製造法
EP0741723A1 (en) Triazole derivatives

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void